ArticleInternational journal of molecular medicine2026
G protein‑coupled receptor kinase 4 governs early kidney development via STAT3 and Nhe3a.
Article in International journal of molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
G protein‑coupled receptor kinase 4 (GRK4) is a member of the receptor phosphorylating GRK family with a well characterized function in renal sodium reabsorption through the modulation of dopaminergic receptors in adults. During embryonic development, GRK4 controls renal cilium development and thus, kidney function. The loss of GRK4 in zebrafish embryos results in pronephric dilatation, massive cilium elongation, glomerular cyst formation and, as a consequence of renal dysfunction, brain edema such as hydrocephalus. Notably, these embryonic functions of GRK4 appear to be independent of G protein‑coupled receptor modulation, although the full extent of the abilities of GRK4 to modulate cellular signaling has remained unclear. The present study aimed to provide further insight on this aspect of the functions of GRK4. Using zebrafish embryos, the present study demonstrates that GRK4 is required for normal pronephros patterning. The loss of Grk4 resulted in the upregulation of the sodium‑hydrogen exchanger 3a (Nhe3a), the zebrafish homologue of human NHE3. The administration of the NHE3 inhibitor, tenapanor, restored normal kidney development and function. Of note, during embryogenesis, this modulation of Nhe3a is not connected to dopaminergic receptor signaling or to a possible nuclear function of GRK4. Instead, the present study identified elevated Stat3 activity as the underlying cause leading to increased Nhe3a transcription and subsequently, to defects in kidney development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.